scholarly journals P2-448: Preclinical evaluation of CDD-0102, a selective M1 agonist with potential utility in Alzheimer's disease

2008 ◽  
Vol 4 ◽  
pp. T505-T505
Author(s):  
William S. Messer ◽  
Karen Steinmetz ◽  
Toufan Parman ◽  
Paul Catz ◽  
Carol Green ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Potential Utility ◽  
Preclinical Evaluation ◽  
M1 Agonist

18 F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease

2016 ◽  
Vol 88 ◽  
pp. 257-266 ◽  
Author(s):  
Johanna Rokka ◽  
Anniina Snellman ◽  
Martti Kaasalainen ◽  
Jarno Salonen ◽  
Cristiano Zona ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Preclinical Evaluation

scholarly journals Preclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer's Disease

2015 ◽  
Vol 4 ◽  
pp. e256 ◽  
Author(s):  
Sepideh Parsi ◽  
Pascal Y Smith ◽  
Claudia Goupil ◽  
Véronique Dorval ◽  
Sébastien S Hébert
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Drug Targets ◽  
Family Members ◽  
Preclinical Evaluation

Development of CDD-0102 as a selective M1 agonist for the treatment of Alzheimer's disease

2002 ◽  
Vol 57 (4) ◽  
pp. 200-213 ◽  
Author(s):  
William S. Messer ◽  
Kenneth A. Bachmann ◽  
Colleen Dockery ◽  
Afif A. El-Assadi ◽  
Ezdihar Hassoun ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
M1 Agonist
Sign in / Sign up

Export Citation Format

Share Document